Skip to main content
Figure 2 | Molecular Cancer

Figure 2

From: miR-630 targets IGF1R to regulate response to HER-targeting drugs and overall cancer cell progression in HER2 over-expressing breast cancer

Figure 2

Clinical relevance of miR-630 in breast cancer. Using a publically available data set (GSE40525) from Gene Expression Omnibus (GEO) the expression of miR-630 was determined in breast cancer tumour tissues compared to matched peritumour tissue. (A) miR-630 was significantly decreased in all breast tumours (n = 56) and also in (B) HER2+ breast cancer tissue (n = 6) compared to matched peritumours. * p <0.05, *** p <0.001

Back to article page

Molecular Cancer

ISSN: 1476-4598